Biomarkers of neuronal protein oxidation (W/S ratio of MAL-6 spin-labeled synaptosomes, phenylhydrazine-reactive protein carbonyls, glutamine synthetase activity, and creatine kinase activity) are significantly altered in brain regions affected by AD (cerebellum, inferior parietal lobule, and hippocampus). Here, GLUL is linked to Alzheimer disease.